In: Accounting
Comparing Profitability Ratios for Competitors
Selected income statement data for Abbott Laboratories, Bristol-Myers Squibb Company, Johnson & Johnson, GlaxoSmithKline plc, and Pfizer, Inc. is presented in the following table:
($ millions) | Abbott Laboratories |
Bristol- Myers Squibb |
Johnson & Johnson |
Glaxo Smith Kline plc |
Pfizer |
---|---|---|---|---|---|
Sales revenue | $20,247 | $11,660 | $74,331 | $35,872 | $49,605 |
Cost of sales | 9,218 | 3,932 | 22,746 | 11,418 | 9,577 |
SG&A expense | 6,530 | 4,822 | 21,954 | 13,466 | 14,097 |
R&D expense | 1,345 | 4,534 | 8,494 | 5,379 | 8,393 |
Interest expense | 150 | 203 | 533 | 1,134 | 1,360 |
Net income | 2,284 | 2,029 | 16,323 | 4,297 | 9,168 |
Required
a. Compute the profit margin (PM) and gross profit margin (GPM)
ratios for each company. (As a British company, GlaxoSmithKline plc
has a statutory tax rate of 26.5% in 2014; assume a statutory rate
of 35% for all other companies.)
(Round your answers to one decimal place.)
Abbott Laboratories |
Bristol- Myers Squibb |
Johnson & Johnson |
Glaxo Smith Kline plc |
Pfizer | |
---|---|---|---|---|---|
PM | Answer | Answer | Answer | Answer | Answer |
GPM | Answer | Answer | Answer | Answer | Answer |
b. Compute the research and development (R&D) expense to
sales ratio and the selling, general and administrative (SG&A)
expense to sales ratio for each company.
(Round your answers to one decimal place.)
Abbott Laboratories |
Bristol- Myers Squibb |
Johnson & Johnson |
Glaxo Smith Kline plc |
Pfizer | |
---|---|---|---|---|---|
R&D ETS | Answer | Answer | Answer | Answer | Answer |
SG&A ETS | Answer | Answer | Answer | Answer | Answer |